AdventHealth Medical Group Orlando

Orlando, Florida 32804

0 studies enrolling now · 4 studies all time

What they study most

Adenocarcinoma, Autoimmune Pancreatitis, Breast Cancer, Cholangiocarcinoma, Chronic Pancreatitis, HER2 Positive Breast Cancer, HER2-positive Breast Cancer, Hepatocellular Carcinoma, Malignant Lymphoma, Metastasis, Neuroendocrine Tumors

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• EchoTip AcuCore Post-Market Clinical Study — Completed